Literature DB >> 27440889

Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.

Wen-Chun Liu1, Jia-Tsrong Jan2, Yun-Ju Huang1, Ting-Hsuan Chen1, Suh-Chin Wu3.   

Abstract

UNLABELLED: Influenza virus hemagglutinin (HA) protein consists of two components, i.e., a globular head region and a stem region that are folded within six disulfide bonds, plus several N-linked glycans that produce a homotrimeric complex structure. While N-linked glycosylation sites on the globular head are variable among different strains and different subtypes, N-linked glycosylation sites in the stem region are mostly well conserved among various influenza virus strains. Targeting highly conserved HA stem regions has been proposed as a useful strategy for designing universal influenza vaccines. Since the HA stem region is constituted by an HA1 N-terminal part and a full HA2 part, we expressed a series of recombinant HA mutant proteins with deleted N-linked glycosylation sites in the HA1 stem and HA2 stem regions of H5N1 and pH1N1 viruses. Unmasking N-glycans in the HA2 stem region (H5 N484A and H1 N503A) was found to elicit more potent neutralizing antibody titers against homologous, heterologous, and heterosubtypic viruses. Unmasking the HA2 stem N-glycans of H5HA but not H1HA resulted in more CR6261-like and FI6v3-like antibodies and also correlated with the increase of cell fusion inhibition activity in antisera. Only H5 N484A HA2 stem mutant protein immunization increased the numbers of antibody-secreting cells, germinal center B cells, and memory B cells targeting the stem helix A epitopes in splenocytes. Unmasking the HA2 stem N-glycans of H5HA mutant proteins showed a significantly improvement in the protection against homologous virus challenges but did so to a less degree for the protection against heterosubtypic pH1N1 virus challenges. These results may provide useful information for designing more effective influenza vaccines. IMPORTANCE: N-linked glycosylation sites in the stem regions of influenza virus hemagglutinin (HA) proteins are mostly well conserved among various influenza virus strains. Targeting highly conserved HA stem regions has been proposed as a useful strategy for designing universal influenza vaccines. Our studies indicate that unmasking the HA2 stem N-glycans of recombinant HA proteins from H5N1 and pH1N1 viruses induced more potent neutralizing antibody titers against homologous and heterosubtypic viruses. However, only immunization with the H5N1 HA2 stem mutant protein can refocus B antibody responses to the helix A epitope for inducing more CR6261-like/FI6v3-like and fusion inhibition antibodies in antisera, resulting in a significant improvement for the protection against lethal H5N1 virus challenges. These results may provide useful information for designing more effective influenza vaccines.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27440889      PMCID: PMC5021406          DOI: 10.1128/JVI.00880-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Preferential localization of IgG memory B cells adjacent to contracted germinal centers.

Authors:  Yuichi Aiba; Kohei Kometani; Megumi Hamadate; Saya Moriyama; Asako Sakaue-Sawano; Michio Tomura; Hervé Luche; Hans Jörg Fehling; Rafael Casellas; Osami Kanagawa; Atsushi Miyawaki; Tomohiro Kurosaki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

2.  Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.

Authors:  David J DiLillo; Peter Palese; Patrick C Wilson; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

Review 3.  Role of stem glycans attached to haemagglutinin in the biological characteristics of H5N1 avian influenza virus.

Authors:  Xiaojian Zhang; Sujuan Chen; Da Yang; Xiao Wang; Jingjing Zhu; Daxin Peng; Xiufan Liu
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

4.  N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication.

Authors:  Ralf Wagner; Dagmar Heuer; Thorsten Wolff; Astrid Herwig; Hans-Dieter Klenk
Journal:  J Gen Virol       Date:  2002-03       Impact factor: 3.891

5.  Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.

Authors:  David J DiLillo; Gene S Tan; Peter Palese; Jeffrey V Ravetch
Journal:  Nat Med       Date:  2014-01-12       Impact factor: 53.440

6.  Cell fusion activity of hepatitis C virus envelope proteins.

Authors:  S Takikawa; K Ishii; H Aizaki; T Suzuki; H Asakura; Y Matsuura; T Miyamura
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

Review 8.  Influenza virus hemagglutinin stalk-based antibodies and vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Curr Opin Virol       Date:  2013-08-24       Impact factor: 7.090

9.  Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain.

Authors:  Suman R Das; Pere Puigbò; Scott E Hensley; Darrell E Hurt; Jack R Bennink; Jonathan W Yewdell
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

10.  New world bats harbor diverse influenza A viruses.

Authors:  Suxiang Tong; Xueyong Zhu; Yan Li; Mang Shi; Jing Zhang; Melissa Bourgeois; Hua Yang; Xianfeng Chen; Sergio Recuenco; Jorge Gomez; Li-Mei Chen; Adam Johnson; Ying Tao; Cyrille Dreyfus; Wenli Yu; Ryan McBride; Paul J Carney; Amy T Gilbert; Jessie Chang; Zhu Guo; Charles T Davis; James C Paulson; James Stevens; Charles E Rupprecht; Edward C Holmes; Ian A Wilson; Ruben O Donis
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  20 in total

1.  Outflanking immunodominance to target subdominant broadly neutralizing epitopes.

Authors:  Davide Angeletti; Ivan Kosik; Jefferson J S Santos; William T Yewdell; Carolyn M Boudreau; Vamsee V A Mallajosyula; Madeleine C Mankowski; Michael Chambers; Madhu Prabhakaran; Heather D Hickman; Adrian B McDermott; Galit Alter; Jayanta Chaudhuri; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

2.  Identification of a Novel Universal Potential Epitope on the Cytoplasmic Tail of H7N9 Virus Hemagglutinin.

Authors:  Xi Liu; Li Ding; Jing Yuan; Jian Liao; Lian Duan; Wenfei Wang; Weiguo Tan; Weiye Yu; Boping Zhou; Xinchun Chen; Zheng Yang
Journal:  Virol Sin       Date:  2019-04-23       Impact factor: 4.327

3.  A small-molecule fusion inhibitor of influenza virus is orally active in mice.

Authors:  Maria J P van Dongen; Rameshwar U Kadam; Jarek Juraszek; Edward Lawson; Boerries Brandenburg; Frederike Schmitz; Wim B G Schepens; Bart Stoops; Harry A van Diepen; Mandy Jongeneelen; Chan Tang; Jan Vermond; Alida van Eijgen-Obregoso Real; Sven Blokland; Divita Garg; Wenli Yu; Wouter Goutier; Ellen Lanckacker; Jaco M Klap; Daniëlle C G Peeters; Jin Wu; Christophe Buyck; Tim H M Jonckers; Dirk Roymans; Peter Roevens; Ronald Vogels; Wouter Koudstaal; Robert H E Friesen; Pierre Raboisson; Dashyant Dhanak; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2019-03-08       Impact factor: 47.728

4.  CspZ FH-Binding Sites as Epitopes Promote Antibody-Mediated Lyme Borreliae Clearance.

Authors:  Yi-Lin Chen; Ashley L Marcinkiewicz; Tristan A Nowak; Rakhi Tyagi Kundu; Zhuyun Liu; Ulrich Strych; Maria Elena Bottazzi; Wen-Hsiang Chen; Yi-Pin Lin
Journal:  Infect Immun       Date:  2022-07-05       Impact factor: 3.609

Review 5.  Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights.

Authors:  Wen-Hsiang Chen; Ulrich Strych; Maria Elena Bottazzi; Yi-Pin Lin
Journal:  Expert Rev Vaccines       Date:  2022-07-22       Impact factor: 5.683

Review 6.  Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.

Authors:  Jian Zheng; Stanley Perlman
Journal:  Curr Opin Virol       Date:  2017-11-21       Impact factor: 7.090

7.  Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.

Authors:  Jessica F Trost; Elizabeth H LeMasters; Feng Liu; Paul Carney; Xiuhua Lu; Kanetsu Sugawara; Seiji Hongo; James Stevens; David A Steinhauer; Terrence Tumpey; Jacqueline M Katz; Min Z Levine; Zhu-Nan Li
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

Review 8.  Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.

Authors:  Carolyn M Boudreau; Galit Alter
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

9.  An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model.

Authors:  Elene A Clemens; Beth C Holbrook; Masaru Kanekiyo; Jonathan W Yewdell; Barney S Graham; Martha A Alexander-Miller
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

10.  Computationally-driven identification of antibody epitopes.

Authors:  Casey K Hua; Albert T Gacerez; Charles L Sentman; Margaret E Ackerman; Yoonjoo Choi; Chris Bailey-Kellogg
Journal:  Elife       Date:  2017-12-04       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.